Synthon BV
Quick facts
Phase 3 pipeline
- Glatiramer Acetate (GTR) · Immunology; Neurology
Glatiramer acetate is a synthetic polypeptide that modulates immune responses by promoting anti-inflammatory T cell and B cell responses, reducing autoimmune attack on myelin.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: